Cargando…
The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges
Tissue inhibitors of metalloproteases (TIMPs) belong to a fascinating protein family expressed in all Metazoa. They act as regulators of the turnover of the extracellular matrix, and they are consistently involved in essential processes. Herein, we recapitulate the main activities of mammalian TIMPs...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409782/ https://www.ncbi.nlm.nih.gov/pubmed/36013323 http://dx.doi.org/10.3390/life12081145 |
_version_ | 1784774935189651456 |
---|---|
author | Costa, Salvatore Ragusa, Maria Antonietta Lo Buglio, Gabriele Scilabra, Simone Dario Nicosia, Aldo |
author_facet | Costa, Salvatore Ragusa, Maria Antonietta Lo Buglio, Gabriele Scilabra, Simone Dario Nicosia, Aldo |
author_sort | Costa, Salvatore |
collection | PubMed |
description | Tissue inhibitors of metalloproteases (TIMPs) belong to a fascinating protein family expressed in all Metazoa. They act as regulators of the turnover of the extracellular matrix, and they are consistently involved in essential processes. Herein, we recapitulate the main activities of mammalian TIMPs (TIMP1–4) in the control of extracellular-matrix degradation and pathologies associated with aberrant proteostasis. We delineate the activity of TIMPs in the control of extracellular matrix (ECM) homeostasis and discuss the diversity of TIMPs across metazoans taking into account the emergence of the components of the ECM during evolution. Thus, the TIMP repertoire herein analysed includes the homologues from cnidarians, which are coeval with the origins of ECM components; protostomes (molluscs, arthropods and nematodes); and deuterostomes (echinoderms and vertebrates). Several questions, including the maintenance of the structure despite low sequence similarity and the strategies for TIMP engineering, shed light on the possibility to use recombinant TIMPs integrating unique features and binding selectivity for therapeutic applications in the treatment of inflammatory pathologies. |
format | Online Article Text |
id | pubmed-9409782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94097822022-08-26 The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges Costa, Salvatore Ragusa, Maria Antonietta Lo Buglio, Gabriele Scilabra, Simone Dario Nicosia, Aldo Life (Basel) Review Tissue inhibitors of metalloproteases (TIMPs) belong to a fascinating protein family expressed in all Metazoa. They act as regulators of the turnover of the extracellular matrix, and they are consistently involved in essential processes. Herein, we recapitulate the main activities of mammalian TIMPs (TIMP1–4) in the control of extracellular-matrix degradation and pathologies associated with aberrant proteostasis. We delineate the activity of TIMPs in the control of extracellular matrix (ECM) homeostasis and discuss the diversity of TIMPs across metazoans taking into account the emergence of the components of the ECM during evolution. Thus, the TIMP repertoire herein analysed includes the homologues from cnidarians, which are coeval with the origins of ECM components; protostomes (molluscs, arthropods and nematodes); and deuterostomes (echinoderms and vertebrates). Several questions, including the maintenance of the structure despite low sequence similarity and the strategies for TIMP engineering, shed light on the possibility to use recombinant TIMPs integrating unique features and binding selectivity for therapeutic applications in the treatment of inflammatory pathologies. MDPI 2022-07-28 /pmc/articles/PMC9409782/ /pubmed/36013323 http://dx.doi.org/10.3390/life12081145 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Costa, Salvatore Ragusa, Maria Antonietta Lo Buglio, Gabriele Scilabra, Simone Dario Nicosia, Aldo The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges |
title | The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges |
title_full | The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges |
title_fullStr | The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges |
title_full_unstemmed | The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges |
title_short | The Repertoire of Tissue Inhibitors of Metalloproteases: Evolution, Regulation of Extracellular Matrix Proteolysis, Engineering and Therapeutic Challenges |
title_sort | repertoire of tissue inhibitors of metalloproteases: evolution, regulation of extracellular matrix proteolysis, engineering and therapeutic challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409782/ https://www.ncbi.nlm.nih.gov/pubmed/36013323 http://dx.doi.org/10.3390/life12081145 |
work_keys_str_mv | AT costasalvatore therepertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT ragusamariaantonietta therepertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT lobugliogabriele therepertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT scilabrasimonedario therepertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT nicosiaaldo therepertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT costasalvatore repertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT ragusamariaantonietta repertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT lobugliogabriele repertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT scilabrasimonedario repertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges AT nicosiaaldo repertoireoftissueinhibitorsofmetalloproteasesevolutionregulationofextracellularmatrixproteolysisengineeringandtherapeuticchallenges |